Want to join the conversation?
$ADS reported that 4Q15 AIR MILES reward miles issued fell 8% versus 4Q14. For FY16, company expects miles issued to grow 3-5%. Epsilon revenue rose 38% in 4Q15, helped by the Conversant acquisition. New facility in India became operational in 4Q15. $ADS ended FY15 with 300 associates in India and hope to increase it to about 1,000 by end 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?